Home

WED., MAY 10, 8AM-5PM

A day-long event tailored to Yale innovators to encourage the sharing of new discoveries and technologies with market potential with the broader investment community.

About

The Yale Innovation Summit is a day-long event tailored to Yale innovators to encourage the sharing of new discoveries and technologies with market potential with the broader investment community.

Check out the 2017 Event Program!

Held at Yale School of Management, and presented by the Office of Cooperative Research, the event featured more 600 attendees and over 35 venture capital firms. More than $1.6M was awarded in grants and prizes.

CONFIRMED 2017 VC FIRMS:

5AM Ventures, Atlas Venture, Elm Street Ventures, Abbvie Ventures, Evolution Life Science Partners, F-Prime Capital Partners, Bulldog Innovation Group, Chart Venture Partners, Nyca Partners, OrbiMed, Polaris Partners, Thayer Street Partners, Vital Venture Capital, New Enterprise Associates, Oak HC/FT, New Leaf Venture Partners, Golden Seeds, Pickwick Capital Partners, Samsung Ventures, Polaris Partners, Axiom Venture Partners, Sanofi-Genzyme BioVentures, LifeSci Capital, Maverick Ventures, Eight Seven Capital, Greater Good Ventures, Trillium Medical Ventures, Blue Ivy Ventures, Fairview Capital Partners, Velocity Fund Partners, Johnson & Johnson, Novartis Venture Funds, Hercules Capital, Agent Capital, Lockheed Martin Ventures & Morningside Group

CONFIRMED 2017 PANELISTS & SPEAKERS:

           

Yale Innovation Summit to Feature Leading Investor and Philanthropist Gerald Chan

The Yale Innovation Summit will feature Gerald Chan as a keynote speaker. Chan is the cofounder of Morningside Group—a private equity and venture capital firm that has invested in a number of biotech companies—and a noted philanthropist. He donated $350M to Harvard, his alma mater, for the renamed Harvard T.H. Chan School of Public Health—the largest such gift in the university’s history. READ MORE.

Biotech Track

The Biotech Track is aimed at those interested in commercializing ideas for drug discovery and biological therapeutics.

Tech Track

The Tech Track is aimed at those interested in commercializing ideas from the physical and computer sciences, engineering, software and services.

Schedule & Program

2017 EVENT PROGRAM HERE

YALE INNOVATION SUMMIT SCHEDULE

7-8am REGISTRATION
7:15-9am CONTINENTAL BREAKFAST
9am WELCOME TO THE YALE INNOVATION SUMMIT
9:10am KEYNOTE ADDRESS

Jim Hornthal

Founder, Launchpad

Zhang Auditorium

*Watch the keynote here!*

10am Audience for tech ventures heads upstairs
BIOTECH TRACK TECH TRACK
10:05am Biotech Venture Investors Panel

“Crossing the Chasm: from Invention to Clinical Trial Funding”

  • Rob Bettigole, Moderator (Elm Street Ventures)
  • Lili Portilla (NIH)
  • Kevin Bitterman (Polaris Partners)
  • Christine Brennan (Novartis)
  • Jason Hafler (Sanofi-Genzyme)
  • James Tobin (Johnson & Johnson)
  • Chau Khuong (OrbiMed)
  • Lou Tartaglia (5AM Ventures)

Zhang Auditorium

Tech Venture Investors Panel

“Corporate Venture Capital Investing in Technology”

  • Chris McLeod, Moderator (Elm Street Ventures)
  • Paul Hermes (Medtronic)
  • Kathleen McGroddy-Goetz (IBM Watson Health)
  • Ken Kaufmann (Hamamatsu)
  • Chris Moran (Lockheed Martin Ventures)
  • Erdogan Cesmeli (GE Ventures)

Room 2400

11am COFFEE BREAK
11:15am BIOTECH PITCH CONTEST

Biotech startups make 5-minute pitches

Zhang Auditorium

ChitRxEngaging chitinases in the treatment of asthma. Team: Geoffrey Chupp, MD, Professor of Medicine (Pulmonary); Director, Yale Center for Asthma and Airways Disease (YCAAD); Director, Pulmonary Function Laboratory, Yale-New Haven Hospital.

VasoRx – Developing a nanoparticle-based therapy to reduce the progression of atherosclerosis. Team: Michael Simons, MD, Robert W. Berliner Professor of Medicine (Cardiology) and Professor of Cell Biology; Pei-Yu Chen, PhD, Associate Research Scientist.

Sidera Medicine –Targeting stem cell-like, invasive subpopulations of glioblastoma and melanoma with a new generation of highly selective small-molecule kinase drugs. Team: Jesse Rinehart, PhD, Associate Professor of Cellular and Molecular Physiology; Farren Isaacs, PhD, Assistant Professor of Molecular, Cellular, and Developmental Biology.

SepDx – An integrated platform for diagnosis and treatment of sepsis. Team: Melissa Davis, MD, Clinical Fellow in Radiology and Biomedical Imaging; David Kaufman, MD, Critical Care Medicine, Pulmonary Disease Medicine, Yale New Haven Bridgeport Hospital.

StraDEFY – Redefining skin cancer prevention and treatment using breakthroughs in nanotechnology. Team: Mark Saltzman, PhD, Goizueta Foundation Professor of Biomedical Engineering, Chemical & Environmental Engineering & Physiology; Michael Girardi, MD, Professor of Dermatology; Director, Residency Program; Vice Chair; Linda Fong, PhD candidate at Yale University.

ADM Therapeutics – A new approach for the rescue of insulin-secreting b-cells in diabetics. Team: Andrew Miranker, PhD, Professor of Molecular Biophysics & Biochemistry.

Rarebase Developing a new generation of chemotherapy agents against cancer stem cells. Team: Andrew Xiao, PhD Associate Professor, Yale Stem Cell Center.

Exolva – Cell-permeable miniature proteins that can deliver better medicine. Team: Alanna Schepartz, PhD, Milton Harris ’29 Ph.D. Professor of Chemistry and Professor of Molecular, Cellular, and Developmental Biology; Rebecca Wissner, Postdoctoral candidate in chemistry.

TECH PITCH CONTEST

Tech startups make 5-minute pitches

Room 2400

Rio Medical – an off-the-shelf filter that plugs into standard IV lines and purges gas from infusions. Team: Sandra Lynne Fryhofer, JD-MBA Candidate at Yale Law School and Yale School of Management; Ketan R. Bulsara, MD, MBA; Matt Wilkens, MBA; Sandra Saldana-Ortega, PhD (MBA ’17); Steven Cramer, PhD.

LaPor – creating a better blue laser diode using porous technology. Team: Jung Han, William A. Norton Professor in Technological Innovation; Ge Yuan, PhD Electrical Engineering (’17).

Py – a mobile platform to improve the way people learn on their phone. Team: Derek Lo (YC ’17).

Alva Health – a wearable device for detection of neurological symptoms. Team: Kevin Sheth, MD, Associate Professor of Neurology and of Neurosurgery; Division Chief, Neurocritical Care and Emergency Neurology; Director, Neuroscience ICU; Chief, Clinical Research, Department of Neurology); Sandra Saldana-Ortega, PhD (SOM ’17); Hitten Zaveri, PhD, Associate Professor in Neurology; Ronald Coifman, PhD, Philips Professor of Math and Computer Science.

CertiKOS – The first fully certified OS kernel that is done economically, proves more properties, runs on concurrent hardware and is truly extensible. Team: Zhong Shao, PhD, Professor of Computer Science.

Trellis – A network survey app that allows users to track and manage teams in order to improve productivity. Team: Nicholas Christakis, MD, PhD, MPH, Director Human Nature Lab and Co-Director, Yale Institute for Network Science; Thomas Keegan, PhD, Director of Yale’s Human Nature Lab; Mark McKnight, Web Developer at Yale’s Human Nature Lab; Marcus Alexander, PhD, scientist in Yale’s Human Nature Lab.

HardID – Hardware fingerprint for IoT devices. Team: Jakub Szefer, Assistant Professor of Electrical Engineering & Computer Science; Wenjie Xiong, Ph.D. candidate in Department of Electrical Engineering at Yale University

Lifeguard – a minimally-invasive, temporary neuro-protection device for aortic valve replacement. Team: Brendan Bell, Postgraduate Associate at Yale SEAS; Tarek Fahmy, PhD, Associate Professor of Biomedical Engineering and Immunobiology; Alexandra Lansky, MD, Professor of Medicine in the section of Cardiology at the Yale School of Medicine; Cody Pietras, Associate Director of Scientific Affairs, Yale Cardiovascular Research Group.

12:30pm LUNCH / POSTER SESSION / NETWORKING

2017 e-posters available here! (password: yale)

————————————

Biotech & Tech Showcase in Zhang Auditorium (Biotech) and Room 2400 (Tech)

1:45pm FEATURED BIOTECH ADDRESS

Roy Herbst, MD

Associate Director for Translational Research, Yale Cancer Center

“The Future of Immuno-Oncology”

 

BIOTECH PANEL DISCUSSION

“The Future of Immuno-Oncology”

  • Chris Denn, Moderator (Goodwin Law)
  • Jason Rhodes (Atlas Venture)
  • Stephen Squinto (OrbiMed)
  • Mary Tanner (Evolution Life Science Partners)
  • Sara Nayeem (New Enterprise Associates)
  • Liam Ratcliffe (New Leaf Ventures)
  • Stephen Knight (F-Prime Capital Partners)
  • Roy Herbst (Yale Cancer Center)

Zhang Auditorium

 

TECH PANEL DISCUSSION

“Building Successful Ventures from Startup to Exit

  • Paul Hughes, Moderator (Wiggin & Dana)
  • Hyuk Jeen-Suh (Samsung Ventures)
  • Patricia Kemp (Oak HC/FT)
  • Jeffrey Reitman (Nyca Partners)
  • Helge Seetzen (Tandem Launch)
  • Jarrod Yuster (Pico Quantitative Trading)

Room 2400

3pm COFFEE BREAK
3:15pm KEYNOTE ADDRESS
GERALD CHAN, Cofounder, Morningside Group “Reflections on Venture Investing in BiotechnologyZhang Auditorium*Watch the keynote and awards ceremony here!
4:15pm CLOSING REMARKS / BLAVATNIK AWARD PRESENTATIONS

Peter Salovey, President of Yale

Zhang Auditorium

5pm Photos & Departure